Press Releases

Teams Assessing Damage in Western North Carolina

Tuesday, Jun 5, 2018 11:39 AM

State and federal emergency management experts are in western North Carolina to begin surveying destruction caused by last week’s torrential rains and mudslides to determine what help individuals a

Cooper Office Comments on Budget

Friday, Jun 1, 2018 11:27 AM

Today, Ford Porter, spokesman for Governor Roy Cooper, shared the following comment after the legislature passed a budget without any amendments being allowed from members.

Governor Cooper to Visit Affected Western Counties Today

Thursday, May 31, 2018 3:23 PM

While rains from Alberto are tapering off across western North Carolina, emergency officials are keeping a close watch on river and lake levels as the threat of flooding, landslides and mudslides remains significant.  Initial reports indicate a landslide yesterday evening near Boone may have claimed two lives.  Rescue teams recovered two bodies from the collapsed home where a gas leak also occurred.

Governor Cooper Comments on Republicans’ Political Water Safety Bills

Thursday, May 24, 2018 2:18 PM

Governor Cooper on HB 972 and SB 724, legislative Republicans’ insufficient proposal to address emerging contaminants in North Carolina’s air and water:

“This legislation makes it harder to keep our air and water clean and it sends funding to the wrong place, providing little more than political cover to legislators who have failed to act. People are tired of politics polluting their water, and state agencies responsible for holding polluters accountable need resources to stop pollution and keep people safe.”

200 New Jobs Coming to Durham County as AveXis Joins North Carolina’s Growing Gene Therapy Cluster

Tuesday, May 22, 2018 1:03 PM

AveXis, Inc., a clinical-stage gene therapy company developing treatments for rare and life-threatening neurological diseases, will locate a new manufacturing center in Durham County creating 200 jobs, Governor Roy Cooper announced today.  The company is expected to invest approximately $55 million in the facility to produce potentially breakthrough therapies to address rare neurological genetic diseases.

Subscribe to News Feed